MLPA® Kits

For a description how to create and adapt MLPA Kits, that are not available on this page, please have a look at our User Manual MLPA.

Import of SALSA MLPA® kit descriptions via the SEQUENCE Pilot operation "Mixes [master file] / button [Import]".

Mix
Version
Date
Region
Application
Vs. 01
05-04-2012
CMT/HNPP region at 17p12 Charcot Marie Tooth Disease
Vs. 03
21-02-2014
CMT/HNPP region at 17p12 Charcot Marie Tooth Disease
P405-A1 Vs. 05 05-02-2016 CMT/HNPP region at 17p12 Charcot Marie Tooth Disease
P405-A1 Vs. A1-01 24-06-2016 CMT/HNPP region at 17p12 Charcot Marie Tooth Disease
Vs. 01
02-04-2013
various CMT2B/2D/2F
Vs. 02
30-06-2015
various CMT2B/2D/2F
Vs. 03
23-09-2016
various CMT2B/2D/2F
Vs. 02
26-12-2011
ADAM22, GPR98, KCNA1, KCNA4, KCNAB1, LGI1, PDYN Autosomal Dominant Lateral Temporal Lobe Epilepsy, ADLTE
P408-A1
Vs. 03
30-11-2012
ADAM22, GPR98, KCNA1, KCNA4, KCNAB1, LGI1, PDYN Autosomal Dominant Lateral Temporal Lobe Epilepsy, ADLTE
P408-A1
Vs. 05
20-11-2015
ADAM22, GPR98, KCNA1, KCNA4, KCNAB1, LGI1, PDYN Autosomal Dominant Lateral Temporal Lobe Epilepsy, ADLTE
P409-A1 Vs. 02 30-11-2012 RASA1 5q14.3 capillary malformations, Parkes Weber syndrome
P409-A1 Vs. 03 30-06-2015 RASA1 5q14.3 capillary malformations, Parkes Weber syndrome
P409-A1 Vs. 04 10-12-2015 RASA1 5q14.3 capillary malformations, Parkes Weber syndrome
P410-A1 Vs. 01 24-04-2012 16p13.2 GRIN2A, 12p13.1 GRIN2B epilepsy, mental retardation
P410-A1 Vs. 02 17-12-2012 16p13.2 GRIN2A, 12p13.1 GRIN2B epilepsy, mental retardation
P410-A1 Vs. 03 29-06-2015 16p13.2 GRIN2A, 12p13.1 GRIN2B epilepsy, mental retardation
P410-A1 Vs. 04 11-12-2015 16p13.2 GRIN2A, 12p13.1 GRIN2B epilepsy, mental retardation
Vs. 01
27-01-2012
ALAD, HMBS, PPOX Porphyrias
Vs. 02
30-11-2012
ALAD, HMBS, PPOX Porphyrias
Vs. 03
27-01-2014
ALAD, HMBS, PPOX Porphyrias
Vs. 05
24-03-2016
ALAD, HMBS, PPOX Porphyrias
Vs. 01
24-01-2012
FECH, UROS, UROD, CPOX Porphyrias
Vs. 02
30-11-2012
FECH, UROS, UROD, CPOX Porphyrias
Vs. 04
24-03-2016
FECH, UROS, UROD, CPOX Porphyrias
Vs. 03
12-09-2013
various Myelodysplastic syndrome
P414-B1
Vs. 06
05-08-2016
various Myelodysplastic syndrome
Vs. 01
14-03-2014
3p21.31 COL7A1, 12q13.13 KRT5 Epidermolysis Bullosa Hereditaria
Vs. 02
14-03-2017
3p21.31 COL7A1, 12q13.13 KRT5 Epidermolysis Bullosa Hereditaria
Vs. 01
04-05-2016
17q21.2 KRT14; 18q11.2 LAMA3; 1q32.2 LAMB3; 1q25.3 LAMC2 Epidermolysis Bullosa Hereditaria
Vs. 03
30-11-2012
BAP1, 3p21.1 Melanocytic tumours, mesothelioma
Vs. 04
07-05-2015
BAP1, 3p21.1 Melanocytic tumours, mesothelioma
Vs. 05
08-01-2016
BAP1, 3p21.1 Melanocytic tumours, mesothelioma
Vs. 06
23-12-2016
BAP1, 3p21.1 Melanocytic tumours, mesothelioma
Vs. 01
08-10-2012
MYH7 14q11.2 Hypertrophic cardiomyopathy
P418-A1 Vs. 02 23-01-2013 MYH7 14q11.2 Hypertrophic cardiomyopathy
P418-A1 Vs. 03 26-09-2014 MYH7 14q11.2 Hypertrophic cardiomyopathy
P418-A1 Vs. 04 14-12-2015 MYH7 14q11.2 Hypertrophic cardiomyopathy
P418-B1 Vs. 05 24-06-2016 MYH7 14q11.2 Hypertrophic cardiomyopathy
Vs. 02
12-03-2013
CDKN2A, CDKN2B, CDK4, MITF E318K Familial melanoma
Vs. 04
26-03-2015
CDKN2A, CDKN2B, CDK4, MITF E318K Familial melanoma